An unresectable Klatskin's tumor?
First Medical Center, University Hospital Hamburg Eppendorf, Hamburg, Germany.
Johannes
J
Hartl
First Medical Center, University Hospital Hamburg Eppendorf, Hamburg, Germany.
Tobias
T
Werner
First Medical Center, University Hospital Hamburg Eppendorf, Hamburg, Germany.
Christoph
C
Schramm
D000369:Aged, 80 and over; D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage; D018951:Antigens, CD20 / Q000032:analysis; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D001650:Bile Duct Neoplasms / Q000175:diagnosis* / Q000473:pathology; D014408:Biomarkers, Tumor / Q000032:analysis; D001706:Biopsy; D002760:Cholangiopancreatography, Endoscopic Retrograde; D003520:Cyclophosphamide / Q000008:administration & dosage; D003937:Diagnosis, Differential; D004317:Doxorubicin / Q000008:administration & dosage; D006500:Hepatic Duct, Common / Q000473:pathology; D006801:Humans; D018285:Klatskin Tumor / Q000175:diagnosis* / Q000473:pathology; D016403:Lymphoma, Large B-Cell, Diffuse / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology / Q000473:pathology; D008297:Male; D009367:Neoplasm Staging; D011237:Predictive Value of Tests; D011241:Prednisone / Q000008:administration & dosage; D000069283:Rituximab; D016896:Treatment Outcome; D014750:Vincristine / Q000008:administration & dosage
D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20; D014408:Biomarkers, Tumor; C571759:R-CHOP protocol; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone